Johns Hopkins ABX Guide
Ceftazidime
Ceftazidime is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Lower respiratory tract infections including pneumonia caused by P. aeruginosa and other Pseudomonas spp., H. influenzae, Klebsiella spp., Enterobacter spp., P. mirabilis, E. coli, Serratia spp., and Citrobacter spp.
- Note: cefotaxime or ceftriaxone preferred for S. pneumoniae.
- Skin and skin-structure infections caused by P. aeruginosa, Klebsiella spp., E. coli,Proteus spp. including P. mirabilisand indole-positive Proteus, Enterobacter spp., and Serratia spp.
- Complicated and uncomplicated urinary tract infections caused by P. aeruginosa,Enterobacter spp., Proteus spp., including P. mirabilis and indole-positive Proteus, Klebsiella spp. and E. coli
- Septicemia caused by P. aeruginosa, Klebsiella spp., H. influenzae, E. coli, and Serratia spp.
- Note: cefotaxime or ceftriaxone preferred for S. pneumoniae.
- Bone and joint infections caused by P. aeruginosa, Klebsiella spp., and Enterobacter spp.
- Gynecologic infections (endometritis, pelvic cellulitis, and other GYN infections) caused by E. coli
- Intra-abdominal Infections, including peritonitis caused by E. coli, Klebsiella spp., and polymicrobial infections caused by aerobic and anaerobic organisms (in combination with metronidazole)
- Central nervous system infections including meningitis, caused by H. influenzae , N. meningitidis, and P. aeruginosa
- Note: cefotaxime or ceftriaxone preferred for S. pneumoniae
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Shunt infections
- Diabetic foot infection (in combination with clindamycin)
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Lower respiratory tract infections including pneumonia caused by P. aeruginosa and other Pseudomonas spp., H. influenzae, Klebsiella spp., Enterobacter spp., P. mirabilis, E. coli, Serratia spp., and Citrobacter spp.
- Note: cefotaxime or ceftriaxone preferred for S. pneumoniae.
- Skin and skin-structure infections caused by P. aeruginosa, Klebsiella spp., E. coli,Proteus spp. including P. mirabilisand indole-positive Proteus, Enterobacter spp., and Serratia spp.
- Complicated and uncomplicated urinary tract infections caused by P. aeruginosa,Enterobacter spp., Proteus spp., including P. mirabilis and indole-positive Proteus, Klebsiella spp. and E. coli
- Septicemia caused by P. aeruginosa, Klebsiella spp., H. influenzae, E. coli, and Serratia spp.
- Note: cefotaxime or ceftriaxone preferred for S. pneumoniae.
- Bone and joint infections caused by P. aeruginosa, Klebsiella spp., and Enterobacter spp.
- Gynecologic infections (endometritis, pelvic cellulitis, and other GYN infections) caused by E. coli
- Intra-abdominal Infections, including peritonitis caused by E. coli, Klebsiella spp., and polymicrobial infections caused by aerobic and anaerobic organisms (in combination with metronidazole)
- Central nervous system infections including meningitis, caused by H. influenzae , N. meningitidis, and P. aeruginosa
- Note: cefotaxime or ceftriaxone preferred for S. pneumoniae
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Shunt infections
- Diabetic foot infection (in combination with clindamycin)
There's more to see -- the rest of this entry is available only to subscribers.
Last updated: December 6, 2017
Citation
Dzintars, Kathryn, and Paul A Pham. "Ceftazidime." Johns Hopkins ABX Guide, The Johns Hopkins University, 2017. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540101/all/Ceftazidime.
Dzintars K, Pham PA. Ceftazidime. Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540101/all/Ceftazidime. Accessed December 3, 2021.
Dzintars, K., & Pham, P. A. (2017). Ceftazidime. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540101/all/Ceftazidime
Dzintars K, Pham PA. Ceftazidime [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. [cited 2021 December 03]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540101/all/Ceftazidime.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ceftazidime
ID - 540101
A1 - Dzintars,Kathryn,Pharm.D., BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2017/12/06/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540101/all/Ceftazidime
PB - The Johns Hopkins University
DB - Johns Hopkins Guide
DP - Unbound Medicine
ER -
